Mission
Seattle Allergy & Asthma Research Institute (SAARI) is a nonprofit clinical research organization founded in 1972, focused on advancing investigation and treatments in allergy, asthma, and immunology. It conducts studies for companies exploring new medication frontiers and treatments for food allergies, environmental allergies, and asthma.
Basic Information
Tax-Exempt
Founded in
1972
EIN
23-7219813
Total Assets
$605.3 thousand
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 3 of 3 goals
At a Glance
Food Allergies Research
Exploration of various treatments and interventions for food allergies.
Asthma Clinical Trials
Ongoing advancements in treatments and methodologies for asthma care.
Community Involvement
Engaging the community by inviting participation in research studies.
Impact Stats
46
Years
Years of Expertise
Years of expertise researching allergies and asthma.
500
Trials
FDA-Approved Clinical Trials
Approximate number of FDA-approved clinical trials conducted.
10
Doctors
Number of Participating Doctors
Number of doctors involved in research efforts at SAARI.
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
51
32
/100
Program Expense Ratio
69.50%
8
/20
Program Revenue Growth
-6.01%
2
/20
Leverage Ratio
0.2408
14
/20
Working Capital Ratio
0.3628
6
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 10.5K | 1.04% |
| Program Services | 1.001M | 98.96% |
| Investment Income | 0 | 0.00% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 1.012M | 100.00% |
